476 related articles for article (PubMed ID: 2952797)
1. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
[TBL] [Abstract][Full Text] [Related]
2. Gold vs D-penicillamine double blind study and followup.
Thomas MH; Rothermich NO; Philips VK; Bergen W; Hedrick SW
J Rheumatol; 1984 Dec; 11(6):764-7. PubMed ID: 6240537
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis as a complication of D-penicillamine therapy in rheumatoid arthritis.
Wysocka K; Fabian F; Listewnik M
Z Rheumatol; 1981; 40(3):135-7. PubMed ID: 7282112
[TBL] [Abstract][Full Text] [Related]
4. [D-penicillamine-induced myasthenia gravis].
Frey RA; Keller F; Michel BA
Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
[TBL] [Abstract][Full Text] [Related]
5. [Neuromuscular complications of D-penicillamine in rheumatoid arthritis].
Dubost JJ; Soubrier M; Bouchet F; Kemeny JL; Lhopitaux R; Bussière JL; Sauvezie B
Rev Neurol (Paris); 1992; 148(3):207-11. PubMed ID: 1604135
[TBL] [Abstract][Full Text] [Related]
6. The toxicity of D-penicillamine in systemic sclerosis.
Steen VD; Blair S; Medsger TA
Ann Intern Med; 1986 May; 104(5):699-705. PubMed ID: 2938530
[TBL] [Abstract][Full Text] [Related]
7. Treatment complications of rheumatoid arthritis with gold, hydroxychloroquine, D-penicillamine, and levamisole.
Husain Z; Runge LA
J Rheumatol; 1980; 7(6):825-30. PubMed ID: 6451692
[TBL] [Abstract][Full Text] [Related]
8. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
[TBL] [Abstract][Full Text] [Related]
9. D-penicillamine and the ocular myasthenic syndrome.
Kimbrough RL; Mewis L; Stewart RH
Ann Ophthalmol; 1981 Oct; 13(10):1171-2. PubMed ID: 7316342
[TBL] [Abstract][Full Text] [Related]
10. [Prolonged neuromuscular blockade during a D. penicillamine-induced myasthenia (author's transl)].
Blanloeil Y; Baron D; Gazeau MF; Nicolas F
Anesth Analg (Paris); 1980; 37(7-8):441-3. PubMed ID: 7425327
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous side effects induced by D-penicillamine in the treatment of rheumatoid arthritis].
Broggini M; Baratelli E; Cappelli A; Crespi E; Filardi PG; Volontè S
Minerva Med; 1990 Mar; 81(3):197-201. PubMed ID: 2138721
[TBL] [Abstract][Full Text] [Related]
12. [Penicillamine: its use in rheumatoid arthritis].
Colombo B; Gerloni V
Recenti Prog Med; 1979 Feb; 66(2):136-87. PubMed ID: 155862
[No Abstract] [Full Text] [Related]
13. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
Leonard PA; Bienz SR; Clegg DO; Ward JR
J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study.
van Rijthoven AW; Dijkmans BA; Thè HS; Meijers KA; Montnor-Beckers ZL; Moolenburgh JD; Boers M; Cats A
J Rheumatol; 1991 Jun; 18(6):815-20. PubMed ID: 1895262
[TBL] [Abstract][Full Text] [Related]
15. [Ocular myasthenia caused by D-penicillamine (author's transl)].
Schmidt D; Kommerell G
Klin Monbl Augenheilkd; 1976 Mar; 168(3):409-13. PubMed ID: 966573
[TBL] [Abstract][Full Text] [Related]
16. [Comparative study of the efficacy of 2 different doses of D-penicillamine in rheumatoid arthritis].
Agababova E; Sidel'nikova S; Aseeva E; Nikol'skaia N; Gaziian R
Ter Arkh; 1981; 53(7):62-7. PubMed ID: 6457408
[No Abstract] [Full Text] [Related]
17. [D-penicillamine induced myasthenia gravis in a patient with rheumatoid arthritis].
Kuriyama S; Hosoya T; Sakai O
Ryumachi; 1991 Jun; 31(3):298-302; discussion 302-3. PubMed ID: 1948449
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.
Bucknall RC
Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):114-7. PubMed ID: 122656
[No Abstract] [Full Text] [Related]
19. [Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis].
Ongerboer de Visser BW; van Soesbergen RM
Ned Tijdschr Geneeskd; 1978 Dec; 122(52):2055-8. PubMed ID: 732905
[No Abstract] [Full Text] [Related]
20. [Myasthenia as a complication of D-penicillamine therapy of rheumatoid arthritis].
Krikunov VP; Gubar' EE; Mogucheva IV; Shagal DI
Ter Arkh; 1987; 59(4):139-41. PubMed ID: 3589994
[No Abstract] [Full Text] [Related]
[Next] [New Search]
